Skip to content
10-Q

Quarterly Report

TIBET PHARMACEUTICALS, INC.

0001144204-11-063286

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Sep 30, 2011 14.85M sh
Operating Cash Flow Q3 2011 · Sep 30, 2011 $3.27M
Operating Cash Flow Q3 2011 · Sep 30, 2010 $5.09M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $25.96M
Cash And Equivalents Q3 2011 · Dec 31, 2010 $7.58M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $8.37M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $4.08M
Stockholders Equity Q3 2011 · Sep 30, 2011 $47.2M
Stockholders Equity Q3 2011 · Dec 31, 2010 $23.48M
Total Liabilities Q3 2011 · Sep 30, 2011 $3.02M
Total Liabilities Q3 2011 · Dec 31, 2010 $3.39M
Current Assets Q3 2011 · Sep 30, 2011 $43.75M
Current Assets Q3 2011 · Dec 31, 2010 $19.8M
Total Assets Q3 2011 · Sep 30, 2011 $50.22M
Total Assets Q3 2011 · Dec 31, 2010 $26.87M
Sga Expense Q3 2011 · Sep 30, 2011 $1.33M
Sga Expense Q3 2011 · Sep 30, 2011 $2.62M
Sga Expense Q3 2011 · Sep 30, 2010 $783.62K
Sga Expense Q3 2011 · Sep 30, 2010 $2.1M
Net Income Q3 2011 · Sep 30, 2011 $1.65M
Net Income Q3 2011 · Sep 30, 2011 $7.75M
Net Income Q3 2011 · Sep 30, 2010 $3.84M
Net Income Q3 2011 · Sep 30, 2010 $10.06M
Operating Income Q3 2011 · Sep 30, 2011 $1.61M
Operating Income Q3 2011 · Sep 30, 2011 $7.67M
Operating Income Q3 2011 · Sep 30, 2010 $3.88M
Operating Income Q3 2011 · Sep 30, 2010 $10.19M
Gross Profit Q3 2011 · Sep 30, 2011 $2.95M
Gross Profit Q3 2011 · Sep 30, 2011 $10.29M
Gross Profit Q3 2011 · Sep 30, 2010 $4.66M
Gross Profit Q3 2011 · Sep 30, 2010 $12.19M
Cost Of Revenue Q3 2011 · Sep 30, 2011 $5.64M
Cost Of Revenue Q3 2011 · Sep 30, 2011 $15.28M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $4.37M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $11.58M
Revenue Q3 2011 · Sep 30, 2011 $8.58M
Revenue Q3 2011 · Sep 30, 2011 $25.57M
Revenue Q3 2011 · Sep 30, 2010 $9.03M
Revenue Q3 2011 · Sep 30, 2010 $23.88M
Dividends Paid Q3 2011 · Sep 30, 2010 $2.49M
Capex Q3 2011 · Sep 30, 2010 $141.83K